...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists.
【24h】

Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists.

机译:基于结构的3D-QSAR研究杂芳基哌嗪衍生物作为5-HT3受体拮抗剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Structure-based 3D-QSAR studies were performed on a series of novel heteroarylpiperazine derivatives as 5-HT(3) receptor antagonists with comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) methods. The compounds were initially docked into the binding pocket of the homology model of 5-HT(3) receptor using GOLD program. The docked conformations with the highest score were then extracted and used to build the 3D-QSAR models, with cross-validated r(cv)(2) values 0.716 and 0.762 for CoMFA and CoMSIA, respectively. The CoMFA and CoMSIA contour plots were also fitted into the 3D structural model of the receptor to identify the key interactions between them, which might be helpful for designing new potent 5-HT(3) receptor antagonists.
机译:基于结构的3D-QSAR研究在一系列新颖的作为5-HT(3)受体拮抗剂的杂芳基哌嗪衍生物上进行了比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)方法。最初使用GOLD程序将化合物对接至5-HT(3)受体同源模型的结合袋中。然后提取出得分最高的对接构象,并用于构建3D-QSAR模型,其中交叉验证的CoMFA和CoMSIA的r(cv)(2)值分别为0.716和0.762。 CoMFA和CoMSIA等高线图也被拟合到受体的3D结构模型中,以识别它们之间的关键相互作用,这可能有助于设计新型有效的5-HT(3)受体拮抗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号